Φορτώνει......
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Microbiol |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society for Microbiology
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879309/ https://ncbi.nlm.nih.gov/pubmed/27008871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00318-16 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|